EUCTR2011-005158-73-DE进行中（未招募）1 期
Superficial vein thrombosis (SVT) treated for forty-five days with Rivaroxaban versus Fondaparinux - SURPRISE
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- GWT-TUD GmbH
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •?acute symptomatic supragenual superficial vein thrombosis of the leg
- •?at least one of the following major risk factor for VTE:
- •-age > 65 years or
- •-male sex or
- •-history of DVT/PE/SVT or
- •-history of cancer or active cancer or
- •-autoimmune disease or
- •-SVT of a non-varicose vein
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 506
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 506
排除标准
- •?renal insufficiency (< 30 ml/min)
- •?high risk of bleeding
- •?indication for therapeutic anticoagulation
研究者
相似试验
已完成
不适用
Assessment of venous thromboembolic disease (VTE) in oncology and haematology patients who presented to the Launceston General Hospital for treatment of their malignant disordervenous thromboembolic diseaseMalignant disorderBlood - Haematological diseasesCancer - Any cancerACTRN12611000762954Clifford Craig Medical Trust Fund766
已完成
不适用
Assessment of venous thromboembolic disease (VTE) in medical patients who presented to the Launceston General Hopspital (LGH)Venous thromboembolism (VTE) among medical patients.Blood - Clotting disordersACTRN12611001255976Clifford Craig Medical Trust Fund1,200
已完成
3 期
Different Doses and Duration of Low Molecular Weight Heparin (Parnaparin)in Superficial Vein ThrombosisThrombophlebitisNCT00362947IRCCS Azienda Ospedaliero-Universitaria di Bologna664
已完成
4 期
Efficacy of Low Molecular Weight Heparin in Superficial Vein ThrombosisSuperficial ThrombophlebitisNCT01245998University Medical Centre Ljubljana68
Unknown
不适用
Outcome of the Venous Thromboembolism (VTE) prevention protocol combined with Enhanced Recovery After Surgery (ERAS) for Acute Care Surgery patients : A Retrospective study of tertiary centerVTEThe patients who age over 14 year-oldAdmit in Acute Care surgery (ACSx) service due to emergency general surgery conditions were included in this studyAcute care surgeryEmergency surgeryTCTR20230407001/A200